226 related articles for article (PubMed ID: 16108021)
21. Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy.
Malpetti M; Passamonti L; Rittman T; Jones PS; Vázquez Rodríguez P; Bevan-Jones WR; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Ann Neurol; 2020 Dec; 88(6):1194-1204. PubMed ID: 32951237
[TBL] [Abstract][Full Text] [Related]
22. In-vivo measurement of activated microglia in dementia.
Cagnin A; Brooks DJ; Kennedy AM; Gunn RN; Myers R; Turkheimer FE; Jones T; Banati RB
Lancet; 2001 Aug; 358(9280):461-7. PubMed ID: 11513911
[TBL] [Abstract][Full Text] [Related]
23. [Imaging of brain microgliosis by PET].
Ouchi Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):925-8. PubMed ID: 20030250
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
25. Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography.
Cumming P; Pedersen MD; Minuzzi L; Mezzomo K; Danielsen EH; Iversen P; Aagaard D; Keiding S; Munk OL; Finsen B
Synapse; 2006 Jun; 59(7):418-26. PubMed ID: 16485266
[TBL] [Abstract][Full Text] [Related]
26. Progression of brain atrophy in PSP and CBS over 6 months and 1 year.
Dutt S; Binney RJ; Heuer HW; Luong P; Attygalle S; Bhatt P; Marx GA; Elofson J; Tartaglia MC; Litvan I; McGinnis SM; Dickerson BC; Kornak J; Waltzman D; Voltarelli L; Schuff N; Rabinovici GD; Kramer JH; Jack CR; Miller BL; Rosen HJ; Boxer AL;
Neurology; 2016 Nov; 87(19):2016-2025. PubMed ID: 27742814
[TBL] [Abstract][Full Text] [Related]
27. Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
Femminella GD; Ninan S; Atkinson R; Fan Z; Brooks DJ; Edison P
J Alzheimers Dis; 2016; 51(4):1275-89. PubMed ID: 27060942
[TBL] [Abstract][Full Text] [Related]
28. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.
Ishizawa K; Dickson DW
J Neuropathol Exp Neurol; 2001 Jun; 60(6):647-57. PubMed ID: 11398841
[TBL] [Abstract][Full Text] [Related]
29. [11C]PK11195 PET imaging of spinal glial activation after nerve injury in rats.
Imamoto N; Momosaki S; Fujita M; Omachi S; Yamato H; Kimura M; Kanegawa N; Shinohara S; Abe K
Neuroimage; 2013 Oct; 79():121-8. PubMed ID: 23611861
[TBL] [Abstract][Full Text] [Related]
30. Advanced structural neuroimaging in progressive supranuclear palsy: Where do we stand?
Stezin A; Lenka A; Jhunjhunwala K; Saini J; Pal PK
Parkinsonism Relat Disord; 2017 Mar; 36():19-32. PubMed ID: 28057431
[TBL] [Abstract][Full Text] [Related]
31. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
[TBL] [Abstract][Full Text] [Related]
32. Microglial activation in young adults with autism spectrum disorder.
Suzuki K; Sugihara G; Ouchi Y; Nakamura K; Futatsubashi M; Takebayashi K; Yoshihara Y; Omata K; Matsumoto K; Tsuchiya KJ; Iwata Y; Tsujii M; Sugiyama T; Mori N
JAMA Psychiatry; 2013 Jan; 70(1):49-58. PubMed ID: 23404112
[TBL] [Abstract][Full Text] [Related]
33. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
Josephs KA; Ishizawa T; Tsuboi Y; Cookson N; Dickson DW
Arch Neurol; 2002 Oct; 59(10):1597-601. PubMed ID: 12374498
[TBL] [Abstract][Full Text] [Related]
34. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure.
Kannan S; Saadani-Makki F; Balakrishnan B; Chakraborty P; Janisse J; Lu X; Muzik O; Romero R; Chugani DC
Dev Neurosci; 2011; 33(3-4):231-40. PubMed ID: 21791891
[TBL] [Abstract][Full Text] [Related]
35. New Perspectives in Radiological and Radiopharmaceutical Hybrid Imaging in Progressive Supranuclear Palsy: A Systematic Review.
Strobel J; Müller HP; Ludolph AC; Beer AJ; Sollmann N; Kassubek J
Cells; 2023 Dec; 12(24):. PubMed ID: 38132096
[TBL] [Abstract][Full Text] [Related]
36. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.
Dickens AM; Vainio S; Marjamäki P; Johansson J; Lehtiniemi P; Rokka J; Rinne J; Solin O; Haaparanta-Solin M; Jones PA; Trigg W; Anthony DC; Airas L
J Nucl Med; 2014 Mar; 55(3):466-72. PubMed ID: 24516258
[TBL] [Abstract][Full Text] [Related]
37. Progressive supranuclear palsy combined with Alzheimer's disease: a clinicopathological study of two autopsy cases.
Sakamoto R; Tsuchiya K; Yoshida R; Itoh Y; Furuta N; Kosuga A; Sugai Y; Mimura M
Neuropathology; 2009 Jun; 29(3):219-29. PubMed ID: 18992014
[TBL] [Abstract][Full Text] [Related]
38. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
Garraux G; Salmon E; Degueldre C; Lemaire C; Laureys S; Franck G
Neuroimage; 1999 Aug; 10(2):149-62. PubMed ID: 10417247
[TBL] [Abstract][Full Text] [Related]
39. Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS.
Hammoud DA; Endres CJ; Chander AR; Guilarte TR; Wong DF; Sacktor NC; McArthur JC; Pomper MG
J Neurovirol; 2005 Aug; 11(4):346-55. PubMed ID: 16162478
[TBL] [Abstract][Full Text] [Related]
40. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.
Kim BC; Choi SM; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Yoon W
Neurol Sci; 2017 Apr; 38(4):627-633. PubMed ID: 28078564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
